WTO AND OTHER ORGANIZATIONS

More

  

The event, which was held under the Chatham House Rule, aimed to identify obstacles and propose solutions for increasing vaccine production and closing the wide gap in vaccination rates between rich and poor countries.

Participants described current and projected production volumes as well as plans for new investments in production capacity. They shared experiences about specific supply chain bottlenecks they were encountering, from export restrictions and raw material shortages to onerous regulatory processes, and exchanged ideas on how these might be addressed.

They discussed issues around the transfer of know-how and technology as well as factors influencing their decisions on licensing intellectual property.

While there was broad agreement on the importance of keeping supply chains open and predictable, different perspectives were expressed on the proposed waiver of the WTO's Trade-Related Intellectual Property Rights Agreement provisions pertaining to vaccines and other products needed to combat COVID-19.

The discussions also touched upon a wide range of issues where greater international cooperation would be beneficial. For instance, multiple participants noted that uncoordinated national recognition of WHO-approved vaccines could leave many vaccinated people unable to travel to places where their vaccines are not recognised. In this regard, they urged countries to accept all WHO-approved vaccines.

The Directors-General of the WHO, Tedros Adhanom Ghebreyesus, the World Intellectual Property Organization (WIPO), Daren Tang, and the WTO, Ngozi Okonjo-Iweala, opened the event. Their remarks are below.

Share

Share


  

Problems viewing this page? If so, please contact webmaster@wto.org giving details of the operating system and web browser you are using.